Related Experiment Videos

In Response to Letter from Fregonara et al. 2019

Richard Nicholas¹, David Brooks^2,3, David Owen²

¹Division of Brain Sciences, Faculty of Medicine, Imperial College London, Hammersmith Hospital Campus, London, UK. r.nicholas@imperial.ac.uk.

Molecular Imaging and Biology

|December 13, 2019

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Genetic subtypes of multiple sclerosis severity are uncoupled from inflammatory lesion burden.

Acta neuropathologica·2026

FCGR3A Polymorphism Controls B-Cell Repopulation Kinetics in People With Multiple Sclerosis Treated With Ocrelizumab.

Neurology(R) neuroimmunology & neuroinflammation·2026

Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial.

Health technology assessment (Winchester, England)·2026

Disease-modifying treatment preferences and decision-making in a multiple sclerosis randomized and observational clinical trial (DELIVER-MS).

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Endocytic accessory proteins assemble clathrin while simultaneously destabilizing protein condensates.

bioRxiv : the preprint server for biology·2026

SMARCA2 PROTAC-dendrimer conjugates for the treatment of non-small cell lung cancer.

Journal of pharmaceutical sciences·2026

See all related articles